Combined Inputs for Manufacturing: Pharmaceutical and Medicine Manufacturing (NAICS 32541) in the United States
IPUEN32541M011000000 • Economic Data from Federal Reserve Economic Data (FRED)
Latest Value
4.10
Year-over-Year Change
-220.59%
Date Range
1/1/1988 - 1/1/2022
Summary
This economic trend measures the combined inputs for manufacturing in the pharmaceutical and medicine industry in the United States. It provides important insights into production activity and supply chain dynamics in a critical sector.
Analysis & Context
This economic indicator provides valuable insights into current market conditions and economic trends. The data is updated regularly by the Federal Reserve and represents one of the most reliable sources for economic analysis.
Understanding this metric helps economists, policymakers, and investors make informed decisions about economic conditions and future trends. The interactive chart above allows you to explore historical patterns and identify key trends over time.
About This Dataset
The Combined Inputs for Manufacturing: Pharmaceutical and Medicine Manufacturing (NAICS 32541) in the United States index tracks the total inputs, including raw materials, energy, and other resources, used in the production of pharmaceuticals and medicines. This metric is closely monitored by economists and policymakers to gauge the health and capacity of the U.S. pharmaceutical manufacturing industry.
Methodology
The data is collected through surveys of pharmaceutical and medicine manufacturing establishments in the United States.
Historical Context
This trend is closely watched by market analysts, central banks, and government agencies to assess the state of the U.S. pharmaceutical supply chain and its implications for inflation, economic growth, and public health.
Key Facts
- The U.S. pharmaceutical industry is the largest in the world, valued at over $500 billion.
- Pharmaceutical manufacturing accounts for over 800,000 jobs in the United States.
- The COVID-19 pandemic significantly disrupted global pharmaceutical supply chains.
FAQs
Q: What does this economic trend measure?
A: This trend measures the total combined inputs, including raw materials, energy, and other resources, used in the production of pharmaceuticals and medicines in the United States.
Q: Why is this trend relevant for users or analysts?
A: This metric is closely monitored by economists, policymakers, and industry analysts to gauge the health and capacity of the U.S. pharmaceutical manufacturing sector, which has significant implications for inflation, economic growth, and public health.
Q: How is this data collected or calculated?
A: The data is collected through surveys of pharmaceutical and medicine manufacturing establishments in the United States.
Q: How is this trend used in economic policy?
A: This trend is closely watched by market analysts, central banks, and government agencies to assess the state of the U.S. pharmaceutical supply chain and its implications for inflation, economic growth, and public health.
Q: Are there update delays or limitations?
A: The data is released on a monthly basis, with a typical lag of several weeks.
Related Trends
Real Sectoral Output for Manufacturing: Pump and Compressor Manufacturing (NAICS 33391) in the United States
IPUEN33391T011000000
Capital Input for Manufacturing: Semiconductor and Other Electronic Component Manufacturing (NAICS 33441) in the United States
IPUEN33441C011000000
Sectoral Output Price Deflator for Manufacturing: Bread and Bakery Product Manufacturing (NAICS 31181) in the United States
IPUEN31181T051000000
Labor Productivity for Manufacturing: Iron and Steel Mills and Ferroalloy Production (NAICS 33111) in the United States
IPUEN33111L000000000
Real Sectoral Output for Manufacturing: Paint, Coating, and Adhesive Manufacturing (NAICS 3255) in the United States
IPUEN3255T011000000
Employment for Manufacturing: Motor Vehicle Electrical and Electronic Equipment (NAICS 336320) in the United States
IPUEN336320W200000000
Citation
U.S. Federal Reserve, Combined Inputs for Manufacturing: Pharmaceutical and Medicine Manufacturing (NAICS 32541) in the United States (IPUEN32541M011000000), retrieved from FRED.